Company / Total Assets
Mirum Pharmaceuticals, Inc. Total Assets History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$842.8M
FY2025
5-year range
$294.7M / $842.8M
FY2021-FY2025
Trend
+25.7%
vs FY2024
Sector context
#91 of 214
Health Care
What the data says
At $843M, Mirum Pharmaceuticals, Inc.'s total assets ranks #91 of 214 in the Health Care sector. Total Assets has increased for 7 consecutive years, from $52M in FY2018 to $843M in FY2025.
Based on SEC 10-K filings.
$843M in FY2025 with a 5-year CAGR of +28.5%.
Improved from $647M to $843M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +33.7%
- 5-Year CAGR
- +28.5%
- 10-Year CAGR
- -
Sector benchmark
#91 of 214 in Health CareTop 43% of 214This company $842.8M Sector average $7.5B
▼
-88.7% below sector average
Key checks
Key Insights
- Mirum Pharmaceuticals, Inc.'s total assets has grown for 7 consecutive years.
- 5-year CAGR of +28.5%, indicating consistent growth.
- In FY2025, total assets increased 25.7% year-over-year.
- Ranks #91 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -26.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $842.8M | +25.7% |
| FY2024 | $670.8M | +3.7% |
| FY2023 | $646.6M | +83.2% |
| FY2022 | $352.9M | +19.8% |
| FY2021 | $294.7M | +22.3% |
| FY2020 | $240.9M | +64.2% |
| FY2019 | $146.7M | +182.3% |
| FY2018 | $52.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026